Interim CEO Brian Mower, according to his CV on MEB website has 17 years experience in commercialising medical devices - this gives me confidence. He is also the CFO so i'd expect a strong hand on the cheque book too. Yes , there has been turbulence in past weeks, but there is plenty of cash in the bank still and much of the work is now done in terms of development and trial activity. There will be funding options for the board to assess appropriately. I'm looking forward to the Call and to hearing from the technical team who so far have been in the background. I think we need also to keep in context, this is, has and always was designed as a tool to assist professionals and consumers and i think people got a bit 'frenzied up' over recent events and didn't interpret the trial results for what they were.
Hold on all, a long way to go.
R (DYOR)
Add to My Watchlist
What is My Watchlist?
